Vice President, Global Medical and Evidence Generation Lead, Covid and Influenza Vaccines and Antivirals @ (January 2023 - May 2025)
Vice President, Global Medical and Scientific Affairs Lead, COVID-19 and mRNA Vaccines @ (June 2021 - December 2022)
Sr. Director, Global Epidemiology and Scientific Affairs Lead, Pipeline Vaccines @ (March 2019 - June 2021)
Sr. Director, Global Epidemiology Lead, Pneumococcal Vaccines @ (February 2017 - February 2019)
Sr. Director, North America Epidemiology Lead, Vaccines @ (August 2016 - January 2017)
Sr. Director, US Epidemiology Lead, Vaccines @ (March 2016 - July 2016)
US Regional Medical Director @ (October 2010 - February 2016)
Consulting Epidemiologist and Data Scientist @ Informagenics, LLC (January 2008 - January 2010)
Epidemiologist, Resource Planning Analyst @ (January 2007 - January 2010)
Quality Control Chemist @ (January 2005 - January 2006)
John McLaughlin Education
The Ohio State University College of Public Health
Ph.D. (Epidemiology)
2008-2010
The Ohio State University College of Public Health
M.S. (Epidemiology)
2006-2007
Miami University
B.A. (Zoology, Medical Sociology)
2001-2005
John McLaughlin Skills
Adobe Creative Suite
Biostatistics
Cancer Research
Epidemiology
Health Services Research
Healthcare
Market Research
Outcomes Research
Pharmaceuticals
Pharmacoeconomics
Pharmacoepidemiology
Pharmacovigilance
Public Health
SAS
SAS/SQL
Stata
Statistical Modeling
Study Design
Vaccines
John McLaughlin Summary
John McLaughlin, based in Philadelphia, PA, US, is currently a Vice President, Scientific Affairs and Epidemiology at Vaxcyte. John McLaughlin brings experience from previous roles at Pfizer. John McLaughlin holds a 2008 - 2010 Ph.D. in Epidemiology @ The Ohio State University College of Public Health. With a robust skill set that includes Adobe Creative Suite, Biostatistics, Cancer Research, Epidemiology, Health Services Research and more. John McLaughlin has 3 emails and 3 mobile phone numbers on RocketReach.
Looking for a different John McLaughlin?
Find contact details for 700 million professionals.